Between 24 and 27 September, 2015 EAMDA organized 45th Annual General Meeting in Belgrade. Friday, September 25 we were able to attend very interesting medical conference with world-renowned lecturers, who had great presentations on the topics important for people with neuromuscular disorders. According to the program, Saturday, September 26 has been dedicated to the social topics and exchange ideas. We would like to thank all participants for attendance.
We are very happy to announce that EAMDA, United Parent Projects Muscular Dystrophy and European Organisation for Rare Diseases - EURORDIS have signed joint letter on Re-examine January 2014 Negative Opinion on Conditional Approval of Ataluren (Translarna) sent to Committee for Medicinal Products for Human Use at European Medicines Agency (EMA). The common effort resulted that EMA granted Conditional Approval for Ataluren (Translarna). The full version of the letter is reachable HERE.
With initiative of United Parent Project Muscular Dystrophy, EAMDA and other world wide known organizations supports activities followed by announced World Duchenne Awareness Day, 7th of September 2014. This day will be a focal point for the worldwide Duchenne Muscular Dystrophy community with the aim to bring this devastating condition to the attention of a wider global audience. More information you can find by visiting this page.